Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2019 1
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Exploiting Canonical TGFβ Signaling in Cancer Treatment.
Liu Q, Chen G, Moore J, Guix I, Placantonakis D, Barcellos-Hoff MH. Liu Q, et al. Among authors: guix i. Mol Cancer Ther. 2022 Jan;21(1):16-24. doi: 10.1158/1535-7163.MCT-20-0891. Epub 2021 Oct 20. Mol Cancer Ther. 2022. PMID: 34670783 Review.
Predictive factors for abiraterone withdrawal syndrome.
Almendros S, Berenguer-Francés MA, Ferrer-González F, Boladeras A, Guix I, Guedea F. Almendros S, et al. Among authors: guix i. Actas Urol Esp (Engl Ed). 2019 Jul-Aug;43(6):300-304. doi: 10.1016/j.acuro.2019.01.003. Epub 2019 May 3. Actas Urol Esp (Engl Ed). 2019. PMID: 31060755 English, Spanish.
Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study.
Guix B, Lejárcegui JA, Tello JI, Zanón G, Henríquez I, Finestres F, Martínez A, Fernandez-Ibiza J, Quinzaños L, Palombo P, Encinas X, Guix I. Guix B, et al. Among authors: guix i. Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):804-10. doi: 10.1016/j.ijrobp.2009.08.009. Epub 2010 Jan 26. Int J Radiat Oncol Biol Phys. 2010. PMID: 20106605
Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types.
Liu Q, Palomero L, Moore J, Guix I, Espín R, Aytés A, Mao JH, Paulovich AG, Whiteaker JR, Ivey RG, Iliakis G, Luo D, Chalmers AJ, Murnane J, Pujana MA, Barcellos-Hoff MH. Liu Q, et al. Among authors: guix i. Sci Transl Med. 2021 Feb 10;13(580):eabc4465. doi: 10.1126/scitranslmed.abc4465. Sci Transl Med. 2021. PMID: 33568520 Free PMC article.